Continuum Advisory, LLC

SEC CIK: 0001846532
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Continuum Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q2 2026): 61
Value: $224
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2024

Holdings of RXRX by Continuum Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	61	$224	<0.1%	+61	New	Holders
Q3 2024	0	$0	0.0%	−300−100.0%	Sold out	Holders
Q2 2024	300	$2.25K	<0.1%	00.0%	Unchanged	Holders
Q1 2024	300	$2.59K	<0.1%	+300	New	Holders